We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
Cap. Flow
-$371M
Cap. Flow %
-2.31%
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$101M
2
ALC icon
Alcon
ALC
+$87.1M
3
OTIS icon
Otis Worldwide
OTIS
+$68.8M
4
MRSH
Marsh
MRSH
+$50M
5
MRK icon
Merck
MRK
+$49.8M

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$56M
2
JPM icon
JPMorgan Chase
JPM
+$42.7M
3
AMZN icon
Amazon
AMZN
+$38.8M
4
AGN
Allergan plc
AGN
+$36.5M
5
MSFT icon
Microsoft
MSFT
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 22.31%
2 Healthcare 14.18%
3 Financials 13.68%
4 Consumer Discretionary 11.52%
5 Communication Services 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATI
651
DELISTED
National Instruments Corp
NATI
$2.33M 0.01%
60,117
-53,119
-47% -$2.01M
OLED icon
652
Universal Display
OLED
$4.19B
$2.33M 0.01%
15,548
-11,116
-42% -$1.63M
TDOC icon
653
Teladoc Health
TDOC
$1.3B
$2.33M 0.01%
12,190
-9,385
-43% -$1.64M
WING icon
654
Wingstop
WING
$3.18B
$2.33M 0.01%
16,737
-28,431
-63% -$3.31M
CGNX icon
655
Cognex
CGNX
$11.3B
$2.33M 0.01%
38,927
-42,217
-52% -$2.29M
HAE icon
656
Haemonetics
HAE
$4B
$2.33M 0.01%
25,955
-9,446
-27% -$954K
CSII
657
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.33M 0.01%
73,697
-30,830
-29% -$1.15M
AXNX
658
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.32M 0.01%
+66,200
New +$2.28M
CHE icon
659
Chemed
CHE
$7.22B
$2.32M 0.01%
5,151
-3,514
-41% -$1.57M
LSTR icon
660
Landstar System
LSTR
$6.21B
$2.32M 0.01%
20,684
-17,292
-46% -$1.85M
AVAV icon
661
AeroVironment
AVAV
$9.45B
$2.32M 0.01%
29,161
-38,890
-57% -$2.5M
LECO icon
662
Lincoln Electric
LECO
$15.4B
$2.32M 0.01%
27,566
-24,863
-47% -$1.97M
LMAT icon
663
LeMaitre Vascular
LMAT
$1.86B
$2.32M 0.01%
87,941
-67,172
-43% -$1.76M
ALRM icon
664
Alarm.com
ALRM
$2.85B
$2.32M 0.01%
35,820
-55,112
-61% -$2.77M
HTLD icon
665
Heartland Express
HTLD
$956M
$2.32M 0.01%
111,461
-88,160
-44% -$1.77M
GWRE icon
666
Guidewire Software
GWRE
$14.2B
$2.32M 0.01%
20,923
-22,998
-52% -$2.21M
APPF icon
667
AppFolio
APPF
$7.04B
$2.32M 0.01%
14,244
-19,931
-58% -$2.61M
AOS icon
668
A.O. Smith
AOS
$8.7B
$2.32M 0.01%
49,178
-46,937
-49% -$2.05M
UNF icon
669
Unifirst Corp
UNF
$5.25B
$2.32M 0.01%
12,945
-12,497
-49% -$2.09M
DCI icon
670
Donaldson
DCI
$11.4B
$2.32M 0.01%
49,790
-47,909
-49% -$2.12M
GH icon
671
Guardant Health
GH
$22.6B
$2.32M 0.01%
28,548
-24,214
-46% -$1.95M
LHCG
672
DELISTED
LHC Group LLC
LHCG
$2.31M 0.01%
13,264
-14,379
-52% -$2.11M
FOXF icon
673
Fox Factory Holding Corp
FOXF
$886M
$2.31M 0.01%
27,978
-68,497
-71% -$4.26M
AAON icon
674
Aaon
AAON
$7.77B
$2.31M 0.01%
63,831
-53,286
-45% -$1.79M
NVRO
675
DELISTED
NEVRO CORP.
NVRO
$2.31M 0.01%
+19,338
New +$2.29M

Similar funds

Aviva's Q2 2020 Portfolio in Review

As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
  • Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
  • Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
  • Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
  • Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
  • Aviva opened 49 new positions and closed 36 in Q2 2020.
  • Aviva's portfolio value rose 18% quarter-over-quarter to $16B.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.